We are live on ! Find out more

Rockwell Medical

RMTI

Market cap $32.1M

7.78 USD

-0.18

2.26%

At close Updated Sep 14, 4:00 PM EDT

1 day

-2.26%

5 days

-1.89%

1 month

4.99%

3 months

21.18%

6 months

-18.53%

Year to date

-9.85%

1 year

-53.13%

5 years

-88.36%

10 years

-98.96%

About: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

Employees: 157

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 75%

Negative 25%

Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

Rockwell Medical Announces Second Quarter 2026 Results

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.

Rockwell Medical Announces Second Quarter 2026 Results

Zacks Investment Research

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical Advances Quality and Regulatory Leadership

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Company.

Rockwell Medical Advances Quality and Regulatory Leadership

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.

Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026

Rockwell Medical Announces 1-for-10 Reverse Stock Split

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock.

Rockwell Medical Announces 1-for-10 Reverse Stock Split

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis products.

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including PureCart, RenalPure, SteriLyte and other products.

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

See News Rankings

Price charts implemented using Lightweight Charts™